Skip to main content

Reid selected for clinical trial development program

Dec. 2, 2021, 8:42 AM

by Tom Wilemon

Sonya Reid, MD, MPH

Sonya Reid, MD, MPH, assistant professor of Medicine, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.

The program aims to increase patient diversity enrollment in clinical trials and develop medicines that safely and effectively treat all populations.

Reid is one of 52 physicians in the first cohort. The program is a $100 million commitment over five years from the Bristol Myers Squibb Foundation to accelerate and expand health equity, diversity and inclusion.

The scholars will participate in multi-level career development, as mentees of established clinical trialists in the first year and then in the second year as mentors to medical students who are underrepresented in medicine through the Clinical Investigator Pipeline Program. By 2027, the Clinical Trial Diversity Career Development Program aims to train 250 community-oriented clinical trialists.

Letters of intent are being accepted now through Jan. 14, 2022, for the second cohort of clinical trial physicians. For medical students, the application period for the Clinical Investigator Pipeline Program is now open and will close on Jan. 28, 2022.

Interested applicants can learn more and apply by visiting

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice